• Je něco špatně v tomto záznamu ?

Soluble endoglin modulates the pro-inflammatory mediators NF-κB and IL-6 in cultured human endothelial cells

M. Varejckova, E. Gallardo-Vara, M. Vicen, B. Vitverova, P. Fikrova, E. Dolezelova, J. Rathouska, A. Prasnicka, K. Blazickova, S. Micuda, C. Bernabeu, I. Nemeckova, P. Nachtigal,

. 2017 ; 175 (-) : 52-60. [pub] 20170321

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023183

AIMS: Endoglin is a transmembrane glycoprotein, that plays an important role in regulating endothelium. Proteolytic cleavage of membrane endoglin releases soluble endoglin (sEng), whose increased plasma levels have been detected in diseases related to the cardiovascular system. It was proposed that sEng might damage vascular endothelium, but detailed information about the potential mechanisms involved is not available. Thus, we hypothesized that sEng contributes to endothelial dysfunction, leading to a pro-inflammatory phenotype by a possible modulation of the TGF-β and/or inflammatory pathways. MAIN METHODS: Human umbilical vein endothelial cells (HUVECs) and Human embryonic kidney cell line (HEK293T) were treated with different sEng concentration and time in order to reveal possible effect on biomarkers of inflammation and TGF-β signaling. IL6 and NFκB reporter luciferase assays, quantitative real-time PCR analysis, Western blot analysis and immunofluorescence flow cytometry were used. KEY FINDINGS: sEng treatment results in activation of NF-κB/IL-6 expression, increased expression of membrane endoglin and reduced expression of Id-1. On the other hand, no significant effects on other markers of endothelial dysfunction and inflammation, including eNOS, peNOS(S1177), VCAM-1, COX-1, COX-2 and ICAM-1 were detected. SIGNIFICANCE: As a conclusion, sEng treatment resulted in an activation of NF-κB, IL-6, suggesting activation of pro-inflammatory phenotype in endothelial cells. The precise mechanism of this activation and its consequence remains to be elucidated. A combined treatment of sEng with other cardiovascular risk factors will be necessary in order to reveal whether sEng is not only a biomarker of cardiovascular diseases, but also a protagonist of endothelial dysfunction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023183
003      
CZ-PrNML
005      
20170831113810.0
007      
ta
008      
170720s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.lfs.2017.03.014 $2 doi
035    __
$a (PubMed)28336397
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Varejckova, Michala $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
245    10
$a Soluble endoglin modulates the pro-inflammatory mediators NF-κB and IL-6 in cultured human endothelial cells / $c M. Varejckova, E. Gallardo-Vara, M. Vicen, B. Vitverova, P. Fikrova, E. Dolezelova, J. Rathouska, A. Prasnicka, K. Blazickova, S. Micuda, C. Bernabeu, I. Nemeckova, P. Nachtigal,
520    9_
$a AIMS: Endoglin is a transmembrane glycoprotein, that plays an important role in regulating endothelium. Proteolytic cleavage of membrane endoglin releases soluble endoglin (sEng), whose increased plasma levels have been detected in diseases related to the cardiovascular system. It was proposed that sEng might damage vascular endothelium, but detailed information about the potential mechanisms involved is not available. Thus, we hypothesized that sEng contributes to endothelial dysfunction, leading to a pro-inflammatory phenotype by a possible modulation of the TGF-β and/or inflammatory pathways. MAIN METHODS: Human umbilical vein endothelial cells (HUVECs) and Human embryonic kidney cell line (HEK293T) were treated with different sEng concentration and time in order to reveal possible effect on biomarkers of inflammation and TGF-β signaling. IL6 and NFκB reporter luciferase assays, quantitative real-time PCR analysis, Western blot analysis and immunofluorescence flow cytometry were used. KEY FINDINGS: sEng treatment results in activation of NF-κB/IL-6 expression, increased expression of membrane endoglin and reduced expression of Id-1. On the other hand, no significant effects on other markers of endothelial dysfunction and inflammation, including eNOS, peNOS(S1177), VCAM-1, COX-1, COX-2 and ICAM-1 were detected. SIGNIFICANCE: As a conclusion, sEng treatment resulted in an activation of NF-κB, IL-6, suggesting activation of pro-inflammatory phenotype in endothelial cells. The precise mechanism of this activation and its consequence remains to be elucidated. A combined treatment of sEng with other cardiovascular risk factors will be necessary in order to reveal whether sEng is not only a biomarker of cardiovascular diseases, but also a protagonist of endothelial dysfunction.
650    _2
$a endoglin $x biosyntéza $7 D000071063
650    12
$a regulace genové exprese $7 D005786
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $x metabolismus $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x chemicky indukované $x metabolismus $7 D007249
650    _2
$a inhibitor diferenciace 1 $x biosyntéza $7 D051798
650    _2
$a interleukin-6 $x biosyntéza $7 D015850
650    _2
$a NF-kappa B $x biosyntéza $7 D016328
650    12
$a signální transdukce $7 D015398
650    _2
$a rozpustnost $7 D012995
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gallardo-Vara, Eunate $u Center for Biological Research, Spanish National Research Council (CSIC), Biomedical Research Networking Center on Rare Diseases (CIBERER), Madrid, Spain.
700    1_
$a Vicen, Matej $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Vitverova, Barbora $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Fikrova, Petra $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Dolezelova, Eva $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Rathouska, Jana $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Prasnicka, Alena $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Blazickova, Katerina $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Micuda, Stanislav $u Charles University, Faculty of Medicine in Hradec Kralove, Department of Pharmacology, Hradec Kralove, Czech Republic.
700    1_
$a Bernabeu, Carmelo $u Center for Biological Research, Spanish National Research Council (CSIC), Biomedical Research Networking Center on Rare Diseases (CIBERER), Madrid, Spain.
700    1_
$a Nemeckova, Ivana $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic.
700    1_
$a Nachtigal, Petr $u Charles University, Faculty of Pharmacy in Hradec Kralove, Department of Biological and Medical Sciences, Hradec Kralove, Czech Republic. Electronic address: petr.nachtigal@faf.cuni.cz.
773    0_
$w MED00003147 $t Life sciences $x 1879-0631 $g Roč. 175, č. - (2017), s. 52-60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28336397 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170831114357 $b ABA008
999    __
$a ok $b bmc $g 1238864 $s 984096
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 175 $c - $d 52-60 $e 20170321 $i 1879-0631 $m Life sciences $n Life Sci $x MED00003147
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...